CUDC-101
Description: An investigational anticancer compound that inhibits histone deacetylases and the EGFR and HER2 receptor tyrosine kinases.
Primary topic: Histone Deacetylase Inhibitors Research (32%)
Wikidata ID: wiki/Q27076925
OpenAlex ID: keywords/cudc-101
